🏛️ Verified NIH Record • Updated 2026-01-05
Phase 3, Randomized, Placebo-Controlled Study of Tinlarebant to Explore Safety and Efficacy in Geographic Atrophy (NCT05949593)
PHase 3, Multicenter, RandOmized, Double-masked, PlacEbo-CoNtrolled Study of TInlarebant to EXplore Safety and Efficacy in the Treatment of Geographic Atrophy (the PHOENIX Study)
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Belite Bio, Inc
🩺 Plain-English Summary (8th-Grade Level)
This Phase 3, multicenter, double-masked, parallel-group, placebo-controlled, randomized, fixed-dose clinical study is designed to evaluate the efficacy and safety of tinlarebant (LBS-008) in subjects diagnosed with GA.
Who can join: Review the eligibility criteria below.
Location: Belite Study Site — Phoenix, Arizona
Age range: 60 Years to 85 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (49 Sites)
Showing the first 25 of 49 sites.
- Belite Study Site — Phoenix, Arizona
- Belite Study Site — Arcadia, California
- Belite Study Site — Beverly Hills, California
- Belite Study Site — Huntington Beach, California
- Belite Study Site — Los Angeles, California
- Belite Study Site — Palo Alto, California
- Belite Study Site — San Diego, California
- Belite Study Site — Lakeland, Florida
- Belite Study Site — Hagerstown, Maryland
- Belite Study Site — Saint Louis Park, Minnesota
- Belite Study Site — Westbury, New York
- Belite Study Site — Cary, North Carolina
- Belite Study Site — Durham, North Carolina
- Belite Study Site — Wake Forest, North Carolina
- Belite Study Site — Portland, Oregon
- Belite Study Site — Philadelphia, Pennsylvania
- Belite Study Site — Sewickley, Pennsylvania
- Belite Study Site — Germantown, Tennessee
- Belite Study Site — Abilene, Texas
- Belite Study Site — Dallas, Texas
- Belite Study Site — San Antonio, Texas
- Belite Study Site — Warrenton, Virginia
- Belite Study Site — Chatswood, New South Wales
- Belite Study Site — Strathfield, New South Wales
- Belite Study Site — Brisbane, Queensland
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Geographic Atrophy
- A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) — Scottsdale, Arizona
- A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Bakersfield, California
- A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy — Gilbert, Arizona
- Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy — Phoenix, Arizona
- A Study in Adults With Geographic Atrophy — Bakersfield, California
Explore by condition: All Geographic Atrophy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.